Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Mimecan Mouse anti-Human, Clone: 2G4, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA524417

Catalog No. PIMA524417


Add to cart

Description

Description

Peptide Sequence: KSRGIKANAF KKLNNLTFLY LDHNALESVP LNLPESLRVI HLQFNNIASI TDDTFCKAND TSYIRDRIEE IRLEGNPIVL GKHPNSFICL KRLPIGSYF

Mimecan induces ectopic bone formation in conjunction with transforming growth factor beta. Mimecan is a small proteoglycan which contains tandem leucine-rich repeats. Mimecan is encoded by the OGN gene, a member of the small leucine-rich proteoglycan (SLRP) family of proteins. Mimecan induces ectopic bone formation in conjunction with transforming growth factor beta (TGF-beta-1 or TGF-beta-2) and may regulate osteoblast differentiation. High expression of mimecan protein may be associated with elevated heart left ventricular mass. Alternative splicing results in multiple transcript variants of mimecan. Alternatively spliced transcript variants that encode mimecan have been found.
Specifications

Specifications

Mimecan
Monoclonal
Unconjugated
OGN
Liquid
OGN
OGN (NP_148935.1, 200 a.a. ∽ 298 a.a) partial recombit protein with GST tag. MW of the GST tag alone is 26 KDa.
Protein A
RUO
Antibody
Monoclonal
Human
ELISA
2G4
PBS with no preservative; pH 7.4
P20774
Mimecan; Osteoglycin; Osteoinductive factor; OIF; SLRR3A; OGN
Mouse
IgG2a, kappa
100 μg
-20° C
Primary
4969
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit